JPMORGAN CHASE & CO - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 79 filers reported holding HUMACYTE INC in Q2 2022. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$180,474
+17.9%
61,595
+15.1%
0.00%
Q2 2023$153,085
-2.5%
53,526
+5.0%
0.00%
Q1 2023$157,000
+198634.2%
50,978
+36.7%
0.00%
Q4 2022$79
-99.9%
37,302
+112.9%
0.00%
Q3 2022$58,000
+23.4%
17,518
+20.1%
0.00%
Q2 2022$47,000
-47.2%
14,586
+16.2%
0.00%
Q1 2022$89,000
-15.2%
12,552
-12.8%
0.00%
Q4 2021$105,00014,3980.00%
Other shareholders
HUMACYTE INC shareholders Q2 2022
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,177,0004.71%
Endowment Wealth Management, Inc. 96,618$682,0000.72%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 36,171$255,0000.24%
Prescott General Partners LLC 625,100$4,413,0000.20%
CenterBook Partners LP 45,752$323,0000.12%
Gladstone Institutional Advisory LLC 144,867$1,0230.07%
Exos Asset Management LLC 18,609$131,0000.06%
Sciencast Management LP 26,300$182,0000.04%
Y-Intercept (Hong Kong) Ltd 17,125$121,0000.03%
Kovack Advisors, Inc. 31,500$222,0000.02%
View complete list of HUMACYTE INC shareholders